回到 StockQ 正常版首頁 |
施羅德拉丁美洲基金-A1/累積
| ||||||||||||
年度報酬率 |
2020 | 2021 | 2022 | 2023 | 2024 |
-13.57% | -4.84% | 17.82% | 19.41% | -21.08% |
施羅德拉丁美洲基金-A1/累積 基金資料 |
1.主要透過投資於拉丁美洲公司的股票,以追求資本增值。2.兼具"計量投資模型"進行國家配置決策,以及"由下至上"個股篩選決策。3.投資組合以MSCI拉美指數成分股為核心,並搭配其他非成分股。4.國家配置較貼近參考指標(MSCI拉丁美洲10/40指數),受額外國家風險影響低,易於追蹤。 |
日期 | 淨值 | 漲跌比例 |
2025/10/06 | 39.4231 | 1.07% |
2025/10/03 | 39.0044 | -0.52% |
2025/10/02 | 39.2095 | -1.42% |
2025/10/01 | 39.7750 | 0.04% |
2025/09/30 | 39.7603 | 0.61% |
2025/09/29 | 39.5201 | 0.26% |
2025/09/26 | 39.4195 | -0.51% |
2025/09/25 | 39.6225 | -0.48% |
2025/09/24 | 39.8125 | 1.61% |
2025/09/23 | 39.1809 | -0.02% |
名稱 | 三個月 | 六個月 | 一年 | 今年 |
施羅德拉丁美洲基金-A1/累積/歐元 | 5.32% | 14.91% | 8.26% | 19.23% |
巴西股市指數 | 1.66% | 12.85% | 8.97% | 19.39% |
墨西哥指數 | 4.19% | 17.40% | 14.82% | 21.91% |
MSCI 新興拉美指數 (price) | 4.79% | 26.41% | 11.36% | 35.20% |
MSCI 巴西指數 (price) | 1.97% | 21.81% | 3.81% | 30.82% |
MSCI 墨西哥指數 (price) | 8.30% | 33.77% | 21.13% | 41.83% |
霸菱拉丁美洲基金-A類/配息/歐元 | 7.48% | 8.42% | 5.60% | 18.16% |
霸菱拉丁美洲基金-A類/配息/美元 | 7.01% | 17.65% | 10.97% | 33.38% |
貝萊德拉丁美洲基金A2/歐元 | 2.84% | 19.18% | 5.73% | 25.09% |
貝萊德拉丁美洲基金A2/美元 | 2.13% | 26.70% | 12.74% | 41.04% |
法巴拉丁美洲股票基金-C股/美元 | -9.05% | -7.42% | -3.95% | -14.34% |
法巴拉丁美洲股票基金-D股/美元 | -16.90% | -15.42% | -12.24% | -21.74% |
瀚亞巴西基金/台幣 | 7.66% | 7.26% | -1.71% | 23.34% |
富達拉丁美洲基金/美元 | 3.90% | 27.99% | 15.73% | 38.10% |
富蘭克林坦伯頓拉丁美洲基金-A/累積/美元 | 2.93% | 24.24% | 17.22% | 37.74% |
富蘭克林坦伯頓拉丁美洲基金-A/年配/美元 | 2.93% | 20.37% | 13.57% | 33.45% |
富蘭克林坦伯頓拉丁美洲基金-B/累積/美元 | 3.03% | 17.38% | 9.19% | 6.36% |
匯豐巴西股票基金AD/美元 | 4.89% | 16.43% | 5.79% | 34.87% |
摩根巴西基金/美元 | -4.33% | 9.61% | 34.69% | -6.41% |
摩根士丹利拉丁美洲股票基金/美元 | -15.74% | 1.75% | 7.74% | 9.56% |
野村巴西基金/台幣 | 9.58% | 6.69% | 4.12% | 25.47% |
拉丁美洲股票基金Y/美元 | 4.22% | 28.62% | 14.09% | 36.65% |
拉丁美洲股票基金A/美元 | 4.01% | 28.11% | 13.18% | 35.81% |
柏瑞拉丁美洲基金/台幣 | 10.90% | 10.78% | 8.44% | 26.45% |
保德信拉丁美洲基金/台幣 | 10.45% | 9.75% | 11.30% | 27.69% |
施羅德拉丁美洲基金-A1/累積/美元 | 4.57% | 18.76% | 14.35% | 33.27% |
| ||||||||||||
StockQ 全球股市指數 © All rights reserved.
|